Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Radiat Prot Dosimetry ; 186(4): 496-506, 2019 Dec 31.
Article in English | MEDLINE | ID: mdl-31330009

ABSTRACT

Due to the radiosensitivity of paediatric patients to X-ray, it is necessary to survey the paediatric DRLs using size-specific dose estimates (SSDE). In the present study, we determined the local diagnostic reference levels (DRLs) for paediatric chest, head and abdomen-pelvis CT examinations and their Surview scans in Kermanshah city, Iran. For ≤1 year, 1-5 years, 5-10 years and 10-15 years the DRLs (mGy) based on SSDE were determined N/A, 6.00, 6.25, 8.27 for abdomen-pelvis, and 8.74, 7.45, 11.15, 10.45 for chest and 19.05, 18.33, 18.22, 20.14 for head examinations, respectively. The differences between body size and default phantom defined in CT scanners are significant and should be considered when determining the DRLs. Based on our findings, use of CTDIv and SSDE parameters for determining DRLs leads to significant different results in children; thus SSDE is suggested as a more accurate index than CTDIV for establishing DRLs in paediatric CT examinations.


Subject(s)
Head/diagnostic imaging , Pelvis/diagnostic imaging , Phantoms, Imaging , Radiography, Abdominal/methods , Radiography, Thoracic/methods , Tomography, X-Ray Computed/methods , Tomography, X-Ray Computed/standards , Adolescent , Body Burden , Body Size , Child , Child, Preschool , Female , Humans , Image Processing, Computer-Assisted/methods , Infant , Iran , Male , Radiation Dosage , Radiography, Abdominal/standards , Radiography, Thoracic/standards , Reference Values , Relative Biological Effectiveness , Risk Assessment
2.
J Cancer Res Ther ; 15(6): 1352-1358, 2019.
Article in English | MEDLINE | ID: mdl-31898672

ABSTRACT

PURPOSE: Nowadays, cancer is one of the most important causes of morbidity and mortality in the world. The ideal aim of radiotherapy is delivering a lethal radiation dose to tumor cells while minimizing radiation exposure to healthy tissues around the tumor. One way to increase the dose in the tumor cells is the use of high-atomic number nanoparticles as radiosensitizer agents in these cells. The aim of this in vitro study was investigating the radiosensitization enhancement potential of the dextran-coated iron oxide nanoparticles (IONPs) on HeLa and MCF-7 cell lines in irradiations with high-energy electron beams. MATERIALS AND METHODS: In this in vitro study, the cytotoxicity level of dextran-coated IONPs at different concentrations (10, 40, and 80 µg/ml) was assessed on HeLa and MCF-7 cell lines. To evaluate the radiosensitivity effect, the nanoparticles were incubated with the cells at different concentrations for 24 h and afterward irradiated with different doses (0, 2, 4, 6, and 8 Gy) of 6 and 12 MeV electron beams. The cells survival fractions were obtained by the methylthiazoletetrazolium assay. RESULTS: Toxicity results of the nanoparticles at 10 and 40 µg/ml concentrations showed no significant cytotoxicity effect. The cells survival rates in groups receiving radiation in the absence and presence of IONPs showed a significant difference. The radiosensitivity enhancement induced by the nanoparticles in MCF-7 cell line was more than it in HeLa cell line. The average of radiosensitization enhancement factor at 10, 40, and 80 µg/ml concentrations and under 6 MeV irradiations obtained as 1.13, 1.19, 1.25, and 1.26, 1.28, 1.29 for HeLa, and MCF-7 cells, respectively. When 12 MeV electron beams were carried out, the values of 1.17, 1.26, 1.32, and 1.29, 1.32, 1.35 were obtained for the cells at the mentioned concentrations, respectively. Furthermore, the significant differences were observed in radiosensitization enhancement between 6 and 12 MeV electron beams irradiations. CONCLUSION: Use of dextran-coated IONPs can increase radiosensitivity and consequently at a given absorbed dose more cell killing will occur in cancerous cells. In other words, these nanoparticles can improve the efficiency of electron therapy.


Subject(s)
Dextrans , Ferric Compounds , Metal Nanoparticles , Particle Accelerators , Radiation-Sensitizing Agents , Radiotherapy , Cell Line, Tumor , Cell Survival/drug effects , Dextrans/chemistry , Dose-Response Relationship, Radiation , Electrons , Ferric Compounds/chemistry , Humans , Metal Nanoparticles/chemistry , Radiation Tolerance , Radiation-Sensitizing Agents/chemistry , Radiotherapy/methods
3.
Int J Radiat Biol ; 93(8): 757-763, 2017 08.
Article in English | MEDLINE | ID: mdl-28452253

ABSTRACT

BACKGROUND AND PURPOSE: The aim of radiotherapy is to deliver lethal damage to cancerous tissue while preserving adjacent normal tissues. Radiation absorbed dose of the tumoral cells can increase when high atomic nanoparticles are present in them during irradiation. Also, the dose rate is an important aspect in radiation effects that determines the biological results of a given dose. This in vitro study investigated the dose-rate effect on the induced radiosensitivity by dextran-coated iron oxide in cancer cells. MATERIALS AND METHODS: HeLa and MCF-7 cells were cultured in vitro and incubated with different concentrations of dextran-coated iron oxide nanoparticles. They were then irradiated with 6 MV photons at dose rates of 43, 185 and 370 cGy/min. The MTT test was used to obtain the cells' survival after 48 h of irradiations. RESULTS: Incubating the cells with the nanoparticles at concentrations of 10, 40 and 80 µg/ml showed no significant cytotoxicity effect. Dextran-coated iron oxide nanoparticles showed more radiosensitivity effect by increasing the dose rate and nanoparticles concentration. Radiosensitization enhancement factors of MCF-7 and HeLa cells at a dose-rate of 370 cGy/min and nanoparticles' concentration of 80 µg/ml were 1.21 ± 0.06 and 1.19 ± 0.04, respectively. CONCLUSION: Increasing the dose rate of 6 MV photons irradiation in MCF-7 and HeLa cells increases the radiosensitization induced by the dextran-coated iron nanoparticles in these cells.


Subject(s)
Dextrans/chemistry , Ferric Compounds/chemistry , Ferric Compounds/pharmacology , Nanoparticles , Radiation Dosage , Radiation-Sensitizing Agents/chemistry , Radiation-Sensitizing Agents/pharmacology , Dose-Response Relationship, Radiation , Ferric Compounds/toxicity , HeLa Cells , Humans , MCF-7 Cells , Radiation-Sensitizing Agents/toxicity , X-Rays
4.
Photodiagnosis Photodyn Ther ; 13: 297-302, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26321747

ABSTRACT

BACKGROUND: 5-Aminolevulinic acid-mediated photodynamic therapy (ALA-PDT) is an effective and noninvasive modality for treatment of several types of non-melanoma skin cancers. This in-vitro study attempted to know whether the killing effect of ALA-PDT on the human melanoma cells (Mel-Rm cell line) could be increased by the presence of 5-fluorouracil (5-FU). METHODS: To evaluate the effect of ALA-PDT in combination with 5-FU on viability of human melanoma Mel-Rm cells, the cells incubated with 5-ALA and 5-FU for 3h in nontoxic concentrations, and subsequently illuminated with a 630 nm light-emitting diode array. The cells viability and cytotoxicity determined by mitochondrial activity and lactate dehydrogenase assays. RESULTS: Combination of ALA-PDT and 5-FU (FU-ALA-PDT) showed a considerable growth inhibition according to the results of MTT assay compared to ALA-PDT. The results of LDH assay also showed a cytotoxicity effect in ALA-PDT; however, the FU-ALA-PDT showed no significantly enhancement in cytotoxicity compared to ALA-PDT using LDH assay. CONCLUSION: The Mel-Rm cells incubation with 5-FU before PDT enhances the efficiency of 5-Aminolevulinic acid-mediated photodynamic therapy.


Subject(s)
Aminolevulinic Acid/administration & dosage , Fluorouracil/administration & dosage , Melanoma, Experimental/drug therapy , Photochemotherapy/methods , Skin Neoplasms/drug therapy , Antimetabolites, Antineoplastic/administration & dosage , Cell Line, Tumor , Drug Synergism , Drug Therapy, Combination/methods , Humans , Melanoma, Experimental/pathology , Photosensitizing Agents/administration & dosage , Skin Neoplasms/pathology , Treatment Outcome
5.
Med Dosim ; 38(1): 25-9, 2013.
Article in English | MEDLINE | ID: mdl-22835650

ABSTRACT

Intensity-modulated radiation therapy (IMRT) can be performed by using compensators. To make a compensator for an IMRT practice, it is required to calculate the effective attenuation coefficient (µ(eff)) of its material, which is affected by various factors. We studied the effect of the variation of the most important factors on the calculation of the µ(eff) of the cerrobend compensator for 6-MV photon beams, including the field size, compensator thickness, and off-axis distance. Experimental measurements were carried out at 100 cm source-to-surface distance and 10 cm depth for the 6-MV photon beams of an Elekta linac using various field size, compensator thickness, and off-axis settings. The field sizes investigated ranged from 4 × 4 to 25 × 25 cm² and the cerrobend compensator thicknesses from 0.5-6 cm. For a fixed compensator thickness, variation of the µ(eff) with the field size ranged from 3.7-6.8%, with the highest value attributed to the largest compensator thickness. At the reference field size of 10 × 10 cm², the µ(eff) varied by 16.5% when the compensator thickness was increased from 0.5-6 cm. However, the variation of the µ(eff) with the off-axis distance was only 0.99% at this field size, whereas for the largest field size, it was more significant. Our results indicated that the compensator thickness and field size have the most significant effect on the calculation of the compensator µ(eff) for the 6-MV photon beam. Therefore, it is recommended to consider these parameters when calculating the compensator thickness for an IMRT practice designed for these beams. The off-axis distance had a significant effect on the calculation of the µ(eff) only for the largest field size. Hence, it is recommended to consider the effect of this parameter only for field sizes larger than 25 × 25 cm².


Subject(s)
Computer-Aided Design , Models, Theoretical , Particle Accelerators/instrumentation , Radiometry/methods , Radiotherapy, Conformal/instrumentation , Computer Simulation , Radiotherapy Dosage , Scattering, Radiation
SELECTION OF CITATIONS
SEARCH DETAIL
...